Alembic announces successful USFDA inspection at joint venture

FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions

Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price

Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.

South Korea Expands Mandatory GMO Labeling to Highly Processed Foods

关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI

FDA Warning Letters Put GMP Back in Focus

Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate

FDA Fast-Tracks U.S. Drug Manufacturing

FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance

Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants